Publications by authors named "Kai Reschke"

Article Synopsis
  • Approximately 95% of deadly mushroom poisonings are due to toxins from certain genera, mainly Amanita, Galerina, and Lepiota, with Lepiota species suspected to have many toxin-producing varieties.
  • The study examined 16 Lepiota species for the presence of amatoxins using sophisticated methods and found specific types of amatoxins in some species, while others showed no signs of these toxins.
  • Two potentially unknown amatoxin derivatives were identified in two species, which could help in distinguishing certain Lepiota species, and overall findings emphasize the importance of understanding the relationship between a species' genetics and its toxicity.
View Article and Find Full Text PDF

Scientific information about biodiversity distribution is indispensable for nature conservation and sustainable management of natural resources. For several groups of animals and plants, such data are available, but for fungi, especially in tropical regions like West Africa, they are mostly missing. Here, information for West African countries about species diversity of fungi and fungus-like organisms (other organisms traditionally studied by mycologists) is compiled from literature and analysed in its historical context for the first time.

View Article and Find Full Text PDF

Although taxonomic knowledge on Tricholoma (Agaricales, Basidiomycota) is fairly comprehensive in northwest Europe, knowledge of the global diversity and distribution of Tricholoma spp. is still sparse. In this study, the diversity and distribution of some Tricholoma spp.

View Article and Find Full Text PDF

The human absorption, distribution, metabolism and elimination study administering radiolabeled drugs to human volunteers is an important clinical study in the development program of new drug candidates. The manufacture of radiolabeled Active Pharmaceutical Ingredients is covered by national drug laws and may come within the scope of regulatory GMP requirements. Additionally, authorities may request an appropriate environmental zoning to minimize the risk of microbiological contaminations particularly during the synthesis of radiolabeled Active Pharmaceutical Ingredients intended for parenteral application.

View Article and Find Full Text PDF